Dickran (Diko) Kazandjian: MRD in BM precedes CR in peripheral blood necessitating new definitions of MRD negativity independently of serum markers.

Rami Manochakian: When NOT having a tissue may not be an issue in advanced lung cancer

Sumanta K. Pal: We are soon to begin a trial of camu camu with IO in kidney cancer, inspired by Bertrand Routy’s excellent paper in Cancer Discovery, at City of Hope.

Angela Mastronuzzi: This literature review shows that targeted therapy is a feasible approach for pediatric low-grade gliomas.

Priscilla Chan: Scientists at the San Francisco Biohub have developed imaging techniques to watch zebrafish embryos develop from a tiny fertilized egg in real time.

Enrique Soto: Very excited about being a part of this study led by Dr. Sophie Pilleron on ecancer.

Paolo Tarantino: The “5 S rules” can help memorize a simple framework to optimally manage ILD.

Nizar Jacques Bahlis: Thrilled to share our work Nature Medicine, led by the very talented Holly Lee, with Dr Paola Neri, Francesco Maura, Leo Rasche, Jonathan Keats.

Fumiko Ladd Chino: How provider, policy, and system changes can make a difference.

Elen Baloyan: Don’t ever forget to say thank you